GeoMx Whole Transcriptome Atlas Grant Program: Vancouver, BC

Open to residents of Canada

Open to Vancouver, BC Researchers

Researchers in Vancouver, BC are invited to apply for this unique grant program that enables the precise mapping of the whole transcriptome to user-defined regions of tissue using the GeoMx® Digital Spatial Profiler.

As part of this grant program, all necessary costs—including experimental reagents from NanoString and initial sequencing reagents from Illumina—will be covered. The two selected applicants will also benefit from comprehensive support throughout the project, including expert training and consultations aimed at optimizing experimental design, sample preparation, and data analysis to ensure robust results.

Full Transcriptome Spatial RNA Analysis

The GeoMx Human Whole Transcriptome Atlas (GeoMx Hs WTA) provides an unbiased view of 18,000+ protein-coding genes. The GeoMx Hs WTA unlocks new pathways to be explored by researchers and enables GeoMx RNA profiling in oncology, immunology, neuroscience, developmental biology, and other diverse fields. GeoMx Hs WTA provides robust and sensitive performance on FFPE or Fresh Frozen samples.

Using the GeoMx Mouse Whole Transcriptome Assay, one can apply spatial transcriptomics to reveal the tissue architecture and underlying function in genetically modified mouse models. Mouse models serve a critical role in understanding developmental biology, disease onset, progression, and treatment.

Project Design Example

  • 1 sample per slide with 48 collections per sample
  • 2 samples per slide with 24 collections per sample
  • 3 samples per slide with 16 collections per sample
  • 4 samples per slide with 12 collections per sample

Award Details

  • 2 slides worth of the WTA probes (Hu or Ms) with 192 total collections
  • Required reagents for the project – Provided by NanoString & project will be run at the UBC MAPcore
  •  1 x P2 flow cell (400 million reads) & sequencing costs – Provided by Illumina
  • Project and data analysis consultation
  • Commercially available morphology kits of your choice:
    • Solid Tumor Kit: Pan-CK, CD45, and SYTO13 nuclear stain
    • Melanoma kit: S100B/Pmel17, CD45, and nuclear stain
    • Alzheimer’s kit: amyloid-beta, Iba-1, and nuclear stain
    • Parkinson’s kit: alpha-synuclein, MAP-2, and nuclear stain

Application Form

Application deadline: June 24, 2024

Terms & Conditions

Publication of Project Results:

Upon project completion, the grant winner agrees to participate in at least one of the following activities relating to the specific project, with specific details of the applicable activity to be mutually agreed upon in good faith by NanoString and each winner: webinar, case study, blog post, or poster presentation. Each winner agrees that NanoString shall have the right to publicly announce the winner’s name and research topic and use anonymized data from the winner’s project in application notes including in marketing materials and seminars.

Eligibility and Requirements:

Applicants must be actively enrolled or employed at an institution or company in a capacity in which they perform life science research and have the ability to analyze samples within 30 days of award notification. Applicants must be part of an institution based in Vancouver, Canada. The winner must be age 18 or older. Members of the immediate families of NanoString employees and directors, and/or persons living in the same household as such persons, are ineligible to participate in this grant program. The grant winners will meet with Nanostring to go through their projects in great detail. They will then work with the Field Application Scientist to get their samples stained with the GeoMx® Whole Transcriptome Atlas. The project will be run at the University of British Columbia’s Molecular and Advanced Pathology Core (MAPcore).


By submitting a grant application, each applicant agrees that NanoString may use his or her name, abstract title, and abstract for marketing purposes. All grant applicants agree that NanoString may process the personal data they provide, including sharing such data with NanoString’s partners, collaborators and other third parties who are obligated to keep the data confidential, and in accordance with NanoString’s privacy policies available at The grant award winner may be required to sign and return an affidavit of eligibility, release of liability, a publicity release, and other appropriate legal documentation reasonably requested by NanoString. No substitution or transfer of the awarded grant is allowed, except as otherwise permitted by NanoString. The award winner is responsible for any local tax liability (city, state, or federal) occurred by winning and accepting the award. If, for any reason, the grant program may not run as planned for any causes beyond the reasonable control of NanoString, then NanoString reserves the right in its sole discretion to cancel, terminate, modify or suspend the grant program. NanoString has not made any warranty, representation, or guarantee, explicit or implied, with respect to the grant award and related services, including, without limitation, their quality or fitness for a particular purpose. This program is void where prohibited or otherwise restricted by law. These terms and conditions and any action related to this grant program will be governed by the laws of the State of Washington without regard to or application of its conflict of law provisions or your state or country of residence. All claims, legal proceedings or litigation arising in connection with these terms and conditions and this grant program will be brought solely in the federal or state courts located in Seattle, Washington, and all applicants consent to the jurisdiction of and venue in such courts and waive any objection as to inconvenient forum. By participating in this grant program, each applicant unconditionally accepts and agrees to comply with and abide by these terms and conditions.